The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors

Convalescent plasma therapy has been described as an attractive approach to treat critically ill patients with COVID-19 (Coronavirus disease 2019). The selection of convalescent plasma donors (CPD) is commonly based on neutralizing antibody titer. A better understanding of the quality of immune resp...

Full description

Bibliographic Details
Main Authors: Marie Kroemer, Laura Boullerot, Mélanie Ramseyer, Laurie Spehner, Christophe Barisien, Eleonore Gravelin, Adeline Renaudin, Fabrice Cognasse, Pierre Gallian, Olivier Hermine, Karine Lacombe, Pierre Tiberghien, Olivier Adotévi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Public Health
Subjects:
neutralizing antibodies
COVID-19
COVID-19 serotherapy
T cell
t-lymphocyte
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.816848/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.816848/full

Similar Items